HeartSciences Inc.
Cash Flow Statement
| Line Item | Jul 2022 | Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-1.6M | $-2.1M | $-1.2M | $-1.0M | $-501.9K |
| Depreciation & Amortization | — | — | — | — | — |
| Depreciation | $6.4K | $6.5K | $6.5K | $6.6K | $7.0K |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $145.7K | $-49.9K | $115.8K | $834 | $1.6K |
| Net Cash from Operating Activities | $-1.8M | $-1.2M | $-966.3K | $-768.1K | $-717.5K |
| Investing Activities | |||||
| Capital Expenditures | $7.2K | — | — | — | — |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-7.2K | — | — | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $5.2M | — | — | — | — |
| Net Change in Cash | $3.4M | $-409.9K | $957.8K | $364.4K | $-717.5K |
| Free Cash Flow | $-1.8M | — | — | — | — |